Enroll a participant
Establish that an eligible, consenting person has entered the Study under a specific Protocol Version at a Study Site that is permitted to enroll.
Object progression
Section titled “Object progression”Candidate -> ContactPermission -> ConsentPresentation -> ConsentDecision -> ScreeningEpisode -> EligibilityEvidence -> EligibilityDecision -> Enrollment -> ProtocolAssignment -> ParticipantScheduleEnrollment behaviour
Section titled “Enrollment behaviour”participant.enroll({ site: openStudySite, consent: effectiveConsent, eligibility: positiveEligibilityDecision, protocolAssignment: applicableProtocolVersion, enrollmentDate: clinicalDate,});Preconditions
Section titled “Preconditions”- The Study Site is currently open for enrollment.
- Consent is effective for the activities and data uses required at enrollment.
- Eligibility was positively determined by an authorized person.
- Eligibility evidence and criteria belong to the applicable Protocol Version.
- No conflicting enrollment exists for the participant identity.
- Applicable cohort, country, site, and Study enrollment limits permit enrollment.
Outcome
Section titled “Outcome”ParticipantEnrolled records:
- Study Participant identity;
- Study and Study Site;
- enrollment date;
- exact Protocol Version assignment;
- consent and eligibility decisions relied upon;
- actor, authority, and evidence.
Follow-on domain behaviour
Section titled “Follow-on domain behaviour”Enrollment makes the participant eligible for downstream setup. It does not itself create EDC, eCOA, randomization, laboratory, or supply state.
ParticipantEnrolled├── ParticipantSchedule may be derived├── EDC Casebook may be initiated├── eCOA assessments may be assigned├── Randomization readiness may be evaluated└── Laboratory participant reference may be establishedProduct review questions
Section titled “Product review questions”- Is enrollment a distinct decision or a consequence of positive eligibility?
- Which consent purposes are required at enrollment versus later activities?
- How are screening numbers and participant numbers corrected?
- When can a screening failure be rescreened under the same identity?